MICKEY THOMAS: Open Payments
NPI 1225381908 · MIDLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$505 in 23 payments from 10 companies in 2025. Trend: 2023 $396 · 2024 $406 · 2025 $505
Food & beverage: $505
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $161 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $80 |
| Novo Nordisk Inc | 4 | $73 |
| Lilly USA, LLC | 2 | $46 |
| Abbott Laboratories | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| Amgen Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $18 |
| ABBVIE INC. | 1 | $17 |
| 3B Medical, Inc. | 1 | $17 |
Products named: FARXIGA, JARDIANCE, Rybelsus, FREESTYLE LIBRE, BREZTRI, Kerendia, ZEPBOUND, REPATHA.
Industry payments across TX — which companies pay providers there.
